Reuters logo
2 months ago
BRIEF-Novabay Pharmaceuticals reports Q1 loss per share $0.26
May 11, 2017 / 8:21 PM / 2 months ago

BRIEF-Novabay Pharmaceuticals reports Q1 loss per share $0.26

1 Min Read

May 11 (Reuters) - Novabay Pharmaceuticals Inc

* Novabay Pharmaceuticals reports first quarter 2017 financial results

* Q1 loss per share $0.26

* Q1 sales $3.7 million versus I/B/E/S view $3.9 million

* Q1 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

* Novabay Pharmaceuticals Inc says expect current financial resources to be sufficient to fund operations and our growth strategy throughout 2017

* Novabay Pharmaceuticals Inc says for Q1 Avenova prescription sales into pharmacy channel were $2.8 million, up 402% year-over-year

* Novabay -Total number of medical professionals who have prescribed Avenova exceeded 9,700, up 33% year-over-year and up 12% from Q4 of 2016

* Novabay Pharmaceuticals Inc says affirming its financial guidance for 2017

* FY2017 earnings per share view $-0.40, revenue view $19.2 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below